fluoxetine has been researched along with Developmental Coordination Disorder in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Machado-Joseph Disease (MJD/SCA3) is an autosomal dominant spinocerebellar degeneration that evolves to disability and death." | 6.71 | Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study. ( Ferro, A; Jardim, LB; Monte, TL; Pereira, ML; Rieder, CR; Rockenback, I; Sequeiros, J; Silveira, I; Tort, AB, 2003) |
"Machado-Joseph Disease (MJD/SCA3) is an autosomal dominant spinocerebellar degeneration that evolves to disability and death." | 2.71 | Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study. ( Ferro, A; Jardim, LB; Monte, TL; Pereira, ML; Rieder, CR; Rockenback, I; Sequeiros, J; Silveira, I; Tort, AB, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Monte, TL | 1 |
Rieder, CR | 1 |
Tort, AB | 1 |
Rockenback, I | 1 |
Pereira, ML | 1 |
Silveira, I | 1 |
Ferro, A | 1 |
Sequeiros, J | 1 |
Jardim, LB | 1 |
1 trial available for fluoxetine and Developmental Coordination Disorder
Article | Year |
---|---|
Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study.
Topics: Adolescent; Adult; Cognition; Depression; Female; Fluoxetine; Humans; Machado-Joseph Disease; Male; | 2003 |